Literature DB >> 23018179

Valosin containing protein (VCP/p97) is a novel substrate for the protein tyrosine phosphatase PTPL1.

Ogan D Abaan1, Wiljan Hendriks, Aykut Uren, Jeffrey A Toretsky, Hayriye V Erkizan.   

Abstract

Identification of Protein Tyrosine Phosphatase (PTP) substrates is critical in understanding cellular role in normal cells as well as cancer cells. We have previously shown that reduction of PTPL1 protein levels in Ewings sarcoma (ES) inhibit cell growth and tumorigenesis. Therefore, we sought to identify novel PTPL1 substrates that may be important for tumorigenesis. In this current work, we demonstrated that mouse embryonic fibroblasts without PTPL1 catalytic activity fail to form foci when transfected with oncogenes. We proved that catalytic activity of PTPL1 is important for ES cell growth. Using a substrate-trapping mutant of PTPL1 we identified putative PTPL1 substrates by mass-spectrometry. One of these putative substrates was characterized as Valosin Containing Protein (VCP/p97). Using multiple biochemical assays we validated VCP as a novel substrate of PTPL1. We also provide evidence that tyrosine phosphorylation of VCP might be important for its midbody localization during cytokinesis. In conclusion, our work identifies VCP as a new substrate for PTPL1, which may be important in cellular transformation. Our investigation link an oncogenic transcription factor EWS-FLI1, with a key transcriptional target protein tyrosine phosphatase PTPL1, and its substrate VCP. Given our observation that PTPL1 catalytic activity is important for cell transformation, our results may also suggest that VCP regulation by PTPL1 might be important for tumorigenesis.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23018179      PMCID: PMC3638858          DOI: 10.1016/j.yexcr.2012.09.003

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  34 in total

1.  In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice.

Authors:  C J Bruns; M T Harbison; H Kuniyasu; I Eue; I J Fidler
Journal:  Neoplasia       Date:  1999-04       Impact factor: 5.715

2.  p97, a protein coping with multiple identities.

Authors:  Philip G Woodman
Journal:  J Cell Sci       Date:  2003-11-01       Impact factor: 5.285

3.  The protein tyrosine phosphatase PTP-BL associates with the midbody and is involved in the regulation of cytokinesis.

Authors:  Lutz Herrmann; Thomas Dittmar; Kai S Erdmann
Journal:  Mol Biol Cell       Date:  2003-01       Impact factor: 4.138

4.  1H, 13C and 15N NMR sequence-specific resonance assignments for rat apo-S100A1(alpha alpha)

Authors:  D M Baldisseri; R R Rustandi; Z Zhang; C Tang; C L Bair; A Landar; A Landar; D B Zimmer; D J Weber
Journal:  J Biomol NMR       Date:  1999-05       Impact factor: 2.835

5.  Tyrosine phosphorylation regulates cell cycle-dependent nuclear localization of Cdc48p.

Authors:  F Madeo; J Schlauer; H Zischka; D Mecke; K U Fröhlich
Journal:  Mol Biol Cell       Date:  1998-01       Impact factor: 4.138

6.  Association of protein-tyrosine phosphatase PTP-BAS with the transcription-factor-inhibitory protein IkappaBalpha through interaction between the PDZ1 domain and ankyrin repeats.

Authors:  K Maekawa; N Imagawa; A Naito; S Harada; O Yoshie; S Takagi
Journal:  Biochem J       Date:  1999-01-15       Impact factor: 3.857

7.  Elevated expression of valosin-containing protein (p97) is associated with poor prognosis of prostate cancer.

Authors:  Yuichi Tsujimoto; Yasuhiko Tomita; Yoshihiko Hoshida; Takuro Kono; Toshitsugu Oka; Shinji Yamamoto; Norio Nonomura; Akihiko Okuyama; Katsuyuki Aozasa
Journal:  Clin Cancer Res       Date:  2004-05-01       Impact factor: 12.531

8.  Biochemical characterization of valosin-containing protein, a protein tyrosine kinase substrate in hematopoietic cells.

Authors:  M Egerton; L E Samelson
Journal:  J Biol Chem       Date:  1994-04-15       Impact factor: 5.157

9.  Mild impairment of motor nerve repair in mice lacking PTP-BL tyrosine phosphatase activity.

Authors:  Derick G Wansink; Wilma Peters; Iris Schaafsma; Roger P M Sutmuller; Frank Oerlemans; Gosse J Adema; Bé Wieringa; Catharina E E M van der Zee; Wiljan Hendriks
Journal:  Physiol Genomics       Date:  2004-06-29       Impact factor: 3.107

Review 10.  Molecular perspectives on p97-VCP: progress in understanding its structure and diverse biological functions.

Authors:  Qing Wang; Changcheng Song; Chou-Chi H Li
Journal:  J Struct Biol       Date:  2004 Apr-May       Impact factor: 2.867

View more
  5 in total

1.  PTPN12/PTP-PEST Regulates Phosphorylation-Dependent Ubiquitination and Stability of Focal Adhesion Substrates in Invasive Glioblastoma Cells.

Authors:  Zhihua Chen; John E Morales; Paola A Guerrero; Huandong Sun; Joseph H McCarty
Journal:  Cancer Res       Date:  2018-05-09       Impact factor: 12.701

Review 2.  Inhibitors of the AAA+ chaperone p97.

Authors:  Eli Chapman; Nick Maksim; Fabian de la Cruz; James J La Clair
Journal:  Molecules       Date:  2015-02-12       Impact factor: 4.411

3.  Proteomic analysis of proton beam irradiated human melanoma cells.

Authors:  Sylwia Kedracka-Krok; Urszula Jankowska; Martyna Elas; Urszula Sowa; Jan Swakon; Agnieszka Cierniak; Pawel Olko; Bozena Romanowska-Dixon; Krystyna Urbanska
Journal:  PLoS One       Date:  2014-01-02       Impact factor: 3.240

Review 4.  Genetic alterations of protein tyrosine phosphatases in human cancers.

Authors:  S Zhao; D Sedwick; Z Wang
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

Review 5.  Dual Role of the PTPN13 Tyrosine Phosphatase in Cancer.

Authors:  Soha Mcheik; Leticia Aptecar; Peter Coopman; Véronique D'Hondt; Gilles Freiss
Journal:  Biomolecules       Date:  2020-12-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.